BridgeMD
Compares treatment options for Lumbar Intervertebral Disc Herniation
Official title A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation
ClinicalTrials.gov ID: NCT07250581
What this study is testing
- What it's testing
- The goal of this study is to explore the indications and application scope of spinal endoscopy combined with annulus fibrosus repair technology, with a focus on verifying the effectiveness of annulus fibrosus suture technology and evaluating its safety, so as to further support the promotion of annulus fibrosus repair technology in patients with lumbar disc herniation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 65
You may be able to join if
- Age: 12 years old to 65 years old, gender not limited;
- Diagnosed with Lumbar disc herniation;
- Preoperative intervertebral disc MRI Pfirrmann grade I - II;
- Conservative treatment is ineffective, and the symptoms significantly affect life;
- Be able to cooperate with long-term follow-up and sign the informed consent form.
You likely can't join if
- Accompanied by lumbar spondylolisthesis, lumbar instability and other lumbar diseases, etc.
- Previous history of lumbar spine surgery;
- Those who have other major physical diseases and are unable to tolerate surgery;
- Diseases such as malnutrition, abnormal bone metabolism, and autoimmune diseases that may affect the postoperative development process;
- Unable to accept regular follow-up visitors
The study team makes the final eligibility decision.
Where it's taking place
- Qingdao, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Qingdao, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.